Canopy Growth Corp

Canopy Growth Corp

CGC · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

0.5612USD-0.01 (-2.20%)

Price History

Full chart

Market Stats

Previous Close0.5738
Open0.554
Day Range0.5432 – 0.58
52-Week Range0.844 – 2.38
Volume2.72M
Market Cap423.02M
P/E (TTM)0.00
Forward P/E20.37
EPS-0.47
Dividend Yield0.00%
Beta2.43
50-Day Avg0.9615
200-Day Avg1.07

About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Luc Mongeau
  • Employees1.13K
  • Headquarters1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8, USA
  • Websitehttps://www.canopygrowth.com

Leadership

  • Mr. Luc MongeauCEO & Director · b. 1967
  • Mr. Thomas Carlton Stewart CPAChief Accounting Officer & CFO · b. 1982
  • Dr. Christelle Gedeon L.L.B., Ph.D.Chief Business Development & Corporate Affairs Officer · b. 1982
  • Ms. Chrissy McHardySenior Vice President of Human Resources
  • Jason GreenHead of Agriculture - Hemp Division
  • Mr. Andrew BevanPresident of Medical Sales
  • Mr. Miles WorneManaging Director of European Markets
  • Mr. David MannerManaging Director of Storz & Bickel GmbH
  • Mr. Christopher RoachSenior Vice President of Supply Chain & Transformation
  • Ms. Megan Amber McCraePresident of Canada Adult Use

Financials

Income Statement

Currency: CAD2010-03-312011-03-312012-03-312013-03-312014-03-312014-12-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue5494.49K4.76K4.14K-1.15M1.90M12.70M39.90M77.95M226.34M398.77M546.65M475.70M333.25M297.15M269.00M284.60M
Growth (%)-+717.49%+6.13%-13.00%--+65.56%+569.50%+214.16%+95.38%+190.37%+76.18%+37.08%-12.98%-29.94%-10.83%-9.47%+5.80%
Cost of Revenue-----731.31K731.31K-6.29M2.26M3.76M137.41M430.46M479.69M663.11M396.78M216.26M189.48M214.93M
Gross Profit5494.49K-4.14K-414.35K414.35K18.99M38.71M74.19M88.93M-31.68M66.96M-187.41M-63.53M80.88M79.51M69.67M
Gross Margin100.00%100.00%-100.00%-36.17%21.84%149.51%97.04%95.18%39.29%-7.95%12.25%-39.40%-19.06%27.22%29.56%24.48%
Operating Expense27.47K24.07K-68.75K-7.15M6.98M21.73M52.80M181.96M704.14M1.64B1.31B831.38M2.57B309.60M196.65M142.78M
Operating Income-26.92K-19.58K-21.39K-64.61K-931.66K-6.74M-6.56M-2.75M-14.08M-107.77M-615.21M-1.67B-1.24B-1.02B-2.63B-228.71M-117.14M-73.11M
Operating Margin-4903.10%-436.27%-449.15%-1559.07%--588.05%-346.10%-21.65%-35.30%-138.26%-271.81%-418.53%-227.47%-214.17%-789.34%-76.97%-43.55%-25.69%
EBITDA-26.92K-19.58K-21.39K-64.61K-925.99K--6.06M938.00K-650.00K-95.70M-567.14M-1.38B-449.65M-52.98M-2.88B-312.83M-479.31M-188.22M
EBITDA Margin-4903.10%-436.27%-449.15%-1559.07%---319.36%7.39%-1.63%-122.78%-250.57%-345.39%-82.26%-11.14%-864.20%-105.28%-178.19%-66.13%
Net Income-26.92K-24.07K-21.39K-64.61K-932.92K-8.93M-8.93M-3.50M-7.52M-67.28M-736.28M-1.32B-1.74B-310.04M-3.28B-657.27M-598.12M-262.91M
Net Income Margin-4903.10%-536.27%-449.15%-1559.07%--779.58%-470.87%-27.53%-18.85%-86.32%-325.30%-331.35%-319.20%-65.18%-983.68%-221.19%-222.35%-92.38%
R&D-----159.65K159.65K721.00K810.00K1.45M15.24M61.81M57.58M32.26M21.72M4.61M1.91M-
R&D as % of Total Revenue-----13.94%8.42%5.68%2.03%1.86%6.73%15.50%10.53%6.78%6.52%1.55%0.71%-
Interest Expense26.92K4.49K4.76K01.27K065.81K140.00K66.00K784.00K18.41M6.72M8.46M103.94M126.16M105.35M74.57M38.19M
Interest Expense % of Total Revenue4903.10%100.00%100.00%0.00%-0.00%3.47%1.10%0.17%1.01%8.14%1.68%1.55%21.85%37.86%35.45%27.72%13.42%

Balance Sheet

Currency: CAD2010-03-312011-03-312012-03-312013-03-312014-03-312014-12-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets588.30K563.21K544.13K507.81K5.15M25.96M47.77M143.36M677.61M1.44B8.73B4.82B6.82B5.61B2.44B1.30B917.70M1.12B
Total Liabilities7.63K6.61K6.48K10.80K1.32M4.29M6.37M19.58M62.87M193.58M1.49B1.18B3.20B1.98B1.68B799.82M430.49M421.14M
Total Equity580.67K556.60K537.65K497.01K3.83M21.67M41.41M123.78M639.76M1.16B6.78B3.43B3.48B3.58B758.43M500.37M487.21M697.59M
Cash37.99K9.58K21.89K10.25K2.09M5.77M21.45M15.40M101.80M322.56M2.48B915.57M1.15B776.00M667.69M170.30M113.81M364.68M
Total Debt----40.42K-1.92M4.02M10.33M8.42M945.98M439.68M1.72B1.64B1.41B668.00M348.40M278.71M
Net Debt-37.99K-9.58K-21.89K-10.25K-2.05M--19.53M-11.38M-91.47M-314.14M-1.53B-475.89M564.53M864.15M745.98M497.70M234.59M-85.97M

Cash Flow

Currency: CAD2010-03-312011-03-312012-03-312013-03-312014-03-312014-12-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-7.00K-28.41K-18.65K-37.00K-1.38M-9.75M-9.75M-12.45M-27.09M-81.51M-535.03M-772.63M-465.73M-545.81M-557.55M-281.95M-165.75M-63.81M
Investing Cash Flow-550.00K-30.00K25.32K-1.06M-11.97M-11.97M-12.30M-18.60M-223.58M-3.23B-347.65M-884.11M230.82M433.38M241.59M-47.79M-21.35M
Financing Cash Flow594.98K-1.00K-4.53M25.40M25.40M18.86M132.10M525.85M5.85B-57.16M1.26B-45.53M-19.69M-465.06M148.66M332.41M
Capital Expenditure00001.05M11.22M11.97M10.71M29.53M178.09M718.82M721.90M174.14M48.11M10.45M4.00M11.28M5.95M
Free Cash Flow-7.00K-28.41K-18.65K-37.00K-2.43M--21.71M-23.16M-56.63M-259.60M-1.25B-1.49B-639.87M-593.92M-568.00M-285.95M-177.03M-69.76M
Dividends Paid-----000000-------
FCF to OCF100.00%100.00%100.00%100.00%176.05%-222.79%186.09%209.00%318.50%234.35%193.43%137.39%108.81%101.87%101.42%106.81%109.33%
Dividend Paid to FCF------0.00%0.00%0.00%0.00%0.00%-------

Earnings

Report DateSep 3, 2014Nov 25, 2014Feb 26, 2015Jun 29, 2015Aug 31, 2015Nov 26, 2015Feb 25, 2016Jun 27, 2016Aug 29, 2016Nov 14, 2016Feb 14, 2017Jun 27, 2017Aug 14, 2017Nov 14, 2017Feb 14, 2018Jun 27, 2018Aug 14, 2018Nov 14, 2018Feb 13, 2019Jun 20, 2019Aug 14, 2019Nov 14, 2019Feb 14, 2020May 29, 2020Aug 10, 2020Nov 9, 2020Feb 9, 2021Jun 1, 2021Aug 6, 2021Nov 5, 2021Feb 9, 2022May 27, 2022Aug 5, 2022Nov 9, 2022Feb 9, 2023Jun 22, 2023Aug 9, 2023Nov 9, 2023Feb 9, 2024May 30, 2024Aug 9, 2024Nov 8, 2024Feb 7, 2025May 30, 2025Aug 8, 2025Nov 7, 2025Feb 6, 2026Jun 15, 2026Aug 7, 2026Nov 6, 2026
EPS Estimate--0.30-0.30-0.40--0.50-0.20-0.02-0.30-0.20-0.35-0.05-0.65-0.50-0.70-0.75-0.13-1.00-2.14-2.83-0.51-3.61-4.66-0.59-4.94-3.58-3.32-0.26-2.88-1.87-3.17-0.32-2.81-2.60-2.26-0.20-2.00-1.16-0.47-0.45-0.37-0.32-0.23-0.25-0.12-0.11-0.05-0.06-0.04-0.03
EPS Actual-0.27-0.60-0.70-0.650.02-0.35-0.35-0.05-0.38-0.40-0.43-0.14-0.86-1.20-1.54-3.03-0.40-13.08-3.62-10.91-0.30-11.08-3.84-1.55-2.573.04-12.86-1.8512.10-0.11-1.61-1.46-8.71-3.29-4.57-1.28-0.49-2.14-2.19-1.03-1.50-1.23-1.06-1.43-0.19-0.01-0.14-0.17-0.02-
Surprise--100.00%-133.33%-62.50%-30.00%-75.00%-150.00%-26.67%-100.00%-22.86%-180.00%-32.31%-140.00%-120.00%-304.00%-207.69%-1208.00%-69.16%-285.51%41.18%-206.93%17.60%-162.71%47.98%184.92%-287.35%-611.54%520.14%94.12%49.21%-356.25%-209.96%-26.54%-102.21%-540.00%75.50%-84.48%-365.96%-128.89%-305.41%-284.38%-360.87%-472.00%-58.33%90.91%-180.00%-183.33%50.00%-
Timing-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap423.02M
Enterprise Value363.83M
Trailing P/E0.00
Forward P/E20.37
Price / Sales1.44
Price / Book0.81
EPS-0.47
Book Value1.16
Revenue (TTM)293.63M
Gross Profit (TTM)83.75M
EBITDA-26.11M
Profit Margin-79.22%
Operating Margin-21.66%
Return on Equity-39.51%
Return on Assets-3.92%
Shares Outstanding423.04M
Shares Float422.17M
Beta2.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 10 analystsTarget 1.20
  • Buy
    2
  • Hold
    4
  • Sell
    1
  • Strong Sell
    3

Ownership Breakdown

Institutions
7.98%
Insiders
0.19%
Retail / Other
91.83%

Top Institutional Holders

  • Tidal Investments LLC.
    8.48M2.00%
  • Morgan Stanley - Brokerage Accounts
    1.97M0.47%
  • Lazard Asset Management LLC
    1.85M0.44%
  • Jane Street Group LLC
    1.58M0.37%
  • The Goldman Sachs Group Inc
    1.26M0.30%
  • Susquehanna International Group, LLP
    980.58K0.23%
  • Royal Bank of Canada
    975.97K0.23%
  • UBS Group AG
    939.40K0.22%
  • NATIONAL BANK OF CANADA /FI/
    858.46K0.20%
  • Federation des caisses Desjardins du Quebec
    795.99K0.19%
  • Sullivan Wood Capital Management, LLC
    690.59K0.16%
  • TD Asset Management Inc
    686.63K0.16%
  • SBI Securities Co Ltd
    616.87K0.15%
  • Millennium Management LLC
    492.57K0.12%
  • SIG North Trading, ULC
    465.49K0.11%

Top Fund Holders

  • ETFMG Alternative Harvest ETF
    9.03M2.13%
  • Global X Marijuana Life Sciences ETF
    3.03M0.72%
  • Lazard Baylight US Sm Cap Eq WW Dist EUR
    1.45M0.34%
  • TD Canadian Equity Index ETF
    526.45K0.12%
  • Mackenzie Canadian Equity ETF
    482.41K0.11%

Stock Splits

  • Dec 20, 20231:10